SPONSOR
Beijing Anzhen Hospital
Total Trials
7
Recruiting
7
Phases
Phase 3
Conditions studied: Atrial Fibrillation (AF)HypertensionCoronary Heart Disease (CHD)Heart FailureCardiogenic ShockCardiac ArrestAcute Respiratory Distress SyndromeAcute Respiratory FailureCatheter AblationAtrial Functional Mitral Regurgitation
Beijing Anzhen Hospital is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Atrial Fibrillation (AF), Hypertension, Coronary Heart Disease (CHD), Heart Failure.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Beijing Anzhen Hospital
How many clinical trials has Beijing Anzhen Hospital sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Beijing Anzhen Hospital, of which 7 are actively recruiting participants. These trials cover conditions including Atrial Fibrillation (AF), Hypertension, Coronary Heart Disease (CHD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Beijing Anzhen Hospital research focus on?
Beijing Anzhen Hospital clinical trials span Atrial Fibrillation (AF), Hypertension, Coronary Heart Disease (CHD), Heart Failure, Cardiogenic Shock, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Beijing Anzhen Hospital clinical trial?
To participate in a Beijing Anzhen Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Beijing Anzhen Hospital trials with current recruitment status updated daily.
Clinical Trials by Beijing Anzhen Hospital
NCT07149688
Recruiting
Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study
Atrial Fibrillation (AF)
NCT04158479
Recruiting
China Extracorporeal Life Support Registry
Cardiogenic Shock
NCT06883864
Recruiting
Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial
Atrial Fibrillation (AF)
NCT05337319
Recruiting
Prospective Registry of the Current Status of Care for Patients With Coronary Artery Disease
Coronary Artery Disease
NCT06822400
Recruiting
Investigation of Tetralogy of Fallot in Neonates
Tetralogy of Fallot (TOF)
NCT04968509 Phase 3
Recruiting
Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
Aortic Stenosis
NCT07357272
Recruiting
A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment
Hypertension (HTN)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology